News

BioSpace4d
Vinay Prasad’s FDA Appointment ‘Anything but Status Quo’
The UCSF professor and frequent YouTube poster has criticized COVID-19 vaccine mandates as well as the accelerated approval ...
FDA names a new vaccine chief. He is a vocal critic of the agency
The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad to lead the agency’s Center for Biologics Evaluation and ...
RFK Jr. takes aim at COVID shots for kids, worrying vaccine experts
Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...
The American Journal of Managed Care5d
Biotech Stocks Slide After FDA Selects Prasad to Lead CBER
The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...
New FDA Leadership Could Raise The Bar For Drug Approvals
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Indian-American Vinay Prasad takes charge as US vaccine chief
Vinay Prasad, an oncologist-hematologist, has been appointed as the new director of the FDA's CBER, overseeing vaccines and ...
Equities Close Lower as Tariff Uncertainty Weighs
Tariff-driven uncertainty has led consumers, businesses and even the Fed to adopt a wait-and-watch mode. The Fed starts its ...
U.S. and Chinese Officials Will Meet to Talk Trade
Scott Bessent, the Treasury secretary, and Jamieson Greer, the United States trade representative, plan to meet with Chinese officials during a trip to Geneva, where they will discuss trade and ...